Actavis recalls
1 recall filed under Actavis. The most recent was published June 2, 2020.
-
Elevated risk · 6+ years ago
Actavis Metformin Hydrochloride Extended-Release Tablets, USP 500mg and 750mg recall: Due to detection of N-Nitrosodimethylamine (NDMA)
Due to detection of N-Nitrosodimethylamine (NDMA)
About this page
Actavis appears here because a federal agency named it as the recalling firm or the brand on the label. A recall is not a judgement about everything the company sells — it covers only the lot codes and models listed in each notice.